ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Corilagin ameliorates macrophages inflammation in atherosclerosis through TLR4-NFκB/MAPK pathway

Meng, Da; Deng, Xin; Wu, Yi; Wu, Jingyi; Zhang, Yaqiong; Zhang, JiaYu; Zhao, Yi; Che, Yanyun*南京农业大学; 云南大学
Heliyon2023-6DOI: 10.1016/j.heliyon.2023.e16960
3被引13阅读
引用收藏
分享

摘要

Corilagin, a polyphenolic tannic acid compound, showed significant anti-inflammatory activity in atherosclerotic mice. The present study aimed to evaluate the effect and mechanism of corilagin in atherosclerosis by in vivo, in vitro and in molecular docking strategies analysis. An athero-sclerotic model was established by feeding ApoE-/-mice a high-fat diet. Murine RAW264.7 macrophages were cultured and induced with lipopolysaccharide (LPS). Treatment with corilagin had a marked inhibitory effect on the plaque area and lipid accumulation in atherosclerotic mice. Corilagin decreased the expression of iNOS and promoted the expression of CD206 in aortic plaque, as well as inhibited the production of proinflammatory factors in HFD-fed ApoE-/-mice and LPS-induced RAW264.6 cell. Corilagin also obviously inhibited the expression of TLR4, reduced the phosphorylation of the JNK, the protein expressions of p38 and NF-& kappa;B pathway. In addition, corilagin markedly diminished the nuclear translocation of NF-& kappa;Bp65. Similarly, mo-lecular docking study suggested that hydrogen bonds were detected between the corilagin and the five proteins (TLR4, Myd88, p65, P38, and JNK) with a significant "CDOCKER energy". These results showed that the antiatherosclerotic effect of corilagin against M1 macrophage polarization and inflammation via suppression the activation of TLR4-NF & kappa;B/MAPK signaling pathway. Therefore, corilagin could be a promising lead compound to develop drugs for the treatment of atherosclerosis.

学科与关键词

关键词
In silicoM1 macrophage polarizationCorilaginAtherosclerosis
相关
加载中…
  • Qingre Huoxue Decoction regulates macrophage polarisation to attenuate atherosclerosis through the inhibition of NF-κB signalling-mediated inflammation
    Jin, Zheng; Luo, Yuan; Zhao, Huanyi; Cui, Jiayan; He, Weifeng; Li, Junlong; Pi, Jianbin; Qing, Lijin*; Wu, Wei*Journal of Ethnopharmacology, 2023, 301: 115787.
  • Tanshinone IIA Alleviates Atherosclerosis Through Inhibition of NF-κB and PPARαE/ABCA1 Signaling Pathways
    He, Dequan; Zhang, Jiawei; Chen, Youquan; Li, Zhiliang*Journal of Biomedical Nanotechnology, 2023, 19(10): 1824-1831.
  • Cyanidin-3-O-β-Glucoside Attenuates Platelet Chemokines and Their in Atherosclerotic Inflammation of Mice
    Yao, Yanling; Zhang, Xiandan; Xu, Yixuan; Zhao, Yimin; Song, Fenglin; Tian, Zezhong; Zhao, Mingzhu; Liang, Ying; Ling, Wenhua; Mao, Yu-Heng*; Yang, Yan*Journal of Agricultural and Food Chemistry, 2022.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Heliyon
发表日期
2023-06
卷期
第 9 卷, 第 6 期
页码
e16960
DOI
10.1016/j.heliyon.2023.e16960
成果收录
SCIE
资助标注
Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Chinese Medicine [2019FF002 (-012), 202101AZ070001-212]; Xing DianYing Cai Foundation [20220273]

作者

  • M

    Meng, Da (第一作者)

    yunnan univ

  • D

    Deng, Xin

    yunnan univ

查看全部 8 位作者收起作者
  • W

    Wu, Yi

    nanjing agr univ

  • W

    Wu, Jingyi

    yunnan univ

  • Z

    Zhang, Yaqiong

    yunnan univ

  • Z

    Zhang, JiaYu

    binzhou med univ

  • Z

    Zhao, Yi

    yunnan univ

  • C

    Che, Yanyun (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417